Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.25
+0.03002.46%
Post-market: 1.19-0.0600-4.80%17:44 EDT
Volume:104.60K
Turnover:128.14K
Market Cap:62.27M
PE:-1.12
High:1.33
Open:1.21
Low:1.19
Close:1.22
Loading ...

Akoya Biosciences, Inc. : Craig-Hallum Cuts to Hold From Buy

THOMSON REUTERS
·
15 Nov 2024

Akoya Biosciences, Inc. : Craig-Hallum Cuts Target Price to $5 From $7

THOMSON REUTERS
·
15 Nov 2024

Piper Sandler Keeps Their Buy Rating on Akoya Biosciences (AKYA)

TIPRANKS
·
15 Nov 2024

Akoya Biosciences price target lowered to $3.50 from $6 at Canaccord

TIPRANKS
·
15 Nov 2024

Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ...

GuruFocus.com
·
15 Nov 2024

Akoya Biosciences Reports Q3 2024 Financial Results

TIPRANKS
·
15 Nov 2024

Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates

Zacks
·
15 Nov 2024

Akoya Biosciences reports Q3 EPS (21c), consensus (20c)

TIPRANKS
·
15 Nov 2024

Akoya Biosciences lowers FY24 revenue view to $80M-$85M, consensus $98.19M

TIPRANKS
·
15 Nov 2024

Akoya: Q3 Earnings Snapshot

Associated Press Finance
·
15 Nov 2024

Akoya Biosciences Q3 2024 GAAP EPS $(0.21) Misses $(0.20) Estimate, Sales $18.80M Miss $25.42M Estimate

Benzinga
·
15 Nov 2024

BRIEF-Akoya Biosciences Q3 Gross Margin 62.3%

Reuters
·
15 Nov 2024

Akoya Biosciences Inc Q3 Shr View $-0.20 -- Lseg Ibes Data

THOMSON REUTERS
·
15 Nov 2024

Akoya Biosciences Inc: Qtrly Loss per Share $0.21

THOMSON REUTERS
·
15 Nov 2024

Akoya Biosciences Inc FY2024 REV View $98.2 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
15 Nov 2024

Akoya Biosciences Q3 Gross Margin 62.3%

THOMSON REUTERS
·
15 Nov 2024

Akoya Biosciences Outlook FY Revenue USD 80-85 Million

THOMSON REUTERS
·
15 Nov 2024

Press Release: Akoya Biosciences Reports Third Quarter 2024 Financial Results

Dow Jones
·
15 Nov 2024

Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
13 Nov 2024